CN Stock MarketDetailed Quotes

600285 Henan Lingrui Pharmaceutical

Watchlist
  • 22.71
  • -0.89-3.77%
Market Closed Dec 5 15:00 CST
12.88BMarket Cap19.05P/E (TTM)

About Henan Lingrui Pharmaceutical Company

The company is a national high-tech enterprise and an A-share listed company whose main business is the production and operation of pharmaceuticals and medical devices. The company has more than 100 kinds of orthopedic, cardiology, encephalology, and anesthesiology products, including Tongluo Pain Relief Cream, Bone Strengthening Musk Pain Relief Cream, Peiyuan Tongnao Capsules, Danlu Tongdu Tablets, Stomach Pain Relief Tablets, Shenqi Sugar Reduction Capsules, Fentanyl Transdermal Patches, etc., as well as national traditional Chinese medicine protected varieties and national medical insurance products and base drug products. Currently, many companies are holding and participating in shares, and have multiple scientific research and production bases. Among them, Ling Rui Pharmaceutical's 10 billion paste production base is leading the domestic market, and Lingrui Xinyang Health Industrial Park is an advanced large-scale oral medicine production base in China. The company's industry is pharmaceutical manufacturing. Its main business involves R&D, production and sales of pharmaceuticals. The main product line focuses on areas with traditional Chinese medicine treatment advantages such as orthopedic diseases and cardiovascular diseases. The company's main products include orthopedic pain relief cream, blood revitalizing and pain relieving tincture, bone strengthening musk pain cream, wet pain relief cream, joint pain relief cream, indomethacin patches, Danlu Tongdu tablets, etc.; the main products for treating chronic diseases such as cardiovascular and cerebrovascular diseases include Peiyuan Tongnao capsules, Shenqi hypoglycemic capsules, Danyu Tongmai granules, etc.; The main products for treating pediatric diseases include abdominal relief paste, pediatric aminophen, hypothermia tablets, etc.; the main treatment products include respiratory diseases Bluestone granules, Quning capsules, etc.; anesthetic products are retinoic fentanyl transdermal patches. Corporate honors: 2011 Governor's Quality Award, National Certified Enterprise Technology Center, Henan Provincial Contract-abiding and Credit-worthy Enterprise, National Pharmaceutical Industry Advanced Team, National Top 50 Traditional Chinese Medicine Industry Enterprises, National Advanced Chinese Medicine System Collective, National Technological Innovation Demonstration Enterprise, etc.

Company Profile

Short Name-A羚锐制药
Symbol-A600285
Company NameHenan Lingrui Pharmaceutical Co.,Ltd.
Listing DateOct 18, 2000
Issue Price8.30
Shares Offered40.00M share(s)
FoundedApr 18, 1999
Listed ExchangeSH Stock Exchange
Legal Representativewei xiong
General Managerwei xiong
Secretaryguoxin feng
Accounting FirmDahua Certified Public Accountants (Special General Partnership)
Securities Representativegaili mao
Legal CounselBeijing Jintai (Wuhan) Law Firm
Employees1226
Phone0376-2973569
Office AddressNo. 666 Jiangjun Road, Xinxian County, Henan
Zip Code465550
Registered AddressNo. 666 Jiangjun Road, Xinxian County, Xinyang City, Henan Province
Fax0376-2987888
Email600285@lingrui.com
Business License410000100020652
BusinessLicense items: pharmaceutical production; drug contract production; drug retail; pharmaceutical wholesale; drug import/export; Class II medical device production; Class III medical device production; Class III medical device management; pharmaceutical excipient production; pharmaceutical excipient sales; health food production; food production; food sales; condiment production; food additive production; formula production for special medical purposes; disinfectant production (excluding hazardous chemicals); cosmetics production; drug clinical trial services; food internet sales; second-class value-added telecommunication services; pharmaceutical internet information services; medical internet information services ; Internet information services (for projects subject to approval according to law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to the relevant department's approval documents or licenses). General items: Class I medical device production; Class I medical device sales; Class II medical device sales; Chinese medicine extract production; health food (prepackaged) sales; food additives sales; formula sales for special medical uses; sporting goods and equipment manufacturing; sporting goods and equipment wholesale; sporting goods and equipment retail; disinfectant sales (excluding hazardous chemicals); household chemicals manufacturing; household chemicals sales; household chemicals manufacturing; daily necessities manufacturing; daily necessities sales; cosmetics retail; medical research and experimental development; engineering and technical research and test development; technical services, technology Development, technical consulting, technology exchange, technology transfer, technology promotion; technology import and export; import and export of goods; information consulting services (excluding licensing information consulting services); Internet sales (other than sales of products requiring permission); housing leasing; non-residential real estate leasing; leasing services (excluding licensed leasing services) (except for projects subject to approval by law, independently carry out business activities based on a business license in accordance with law)

Company Executives

  • Name
  • Position
  • Salary
  • wei xiong
  • Chairman, Directors, General Manager, Chairman of the Strategy Committee, Nomination Committee Members, Member of the Remuneration and Assessment Committee
  • 1.80M
  • guoxin feng
  • Directors, Board Secretary
  • 953.90K
  • xizhen wu
  • Directors, Deputy General Manager, Nomination Committee Members
  • --
  • zirun pan
  • Directors, Audit Committee Member
  • 947.70K
  • zhijun zhao
  • Directors, Audit Committee Members, Strategy Committee Member
  • 707.10K
  • yan chen
  • Directors, Deputy General Manager, Member of the Remuneration and Assessment Committee
  • 972.30K
  • qinyu zhang
  • Independent Directors, Nomination Committee Members, Strategy Committee Members, Chairman of the Remuneration and Assessment Committee, Audit Committee Members
  • --
  • hui li
  • Independent Directors, Strategy Committee Member, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee, Audit Committee Member
  • 41.70K
  • jun yang
  • Independent Directors, Chairman of the Audit Committee, Strategy Committee Member, Nomination Committee Members
  • 58.30K
  • gaili mao
  • Securities Affairs Representative
  • --
  • jin li
  • Chairman of the Supervisory Board, Auditors
  • --
  • jiashu jiang
  • Auditors
  • 618.20K
  • qiang ye
  • Deputy General Manager
  • 938.10K
  • lei li
  • Deputy General Manager
  • 783.70K
  • huibin wu
  • Deputy General Manager
  • 1.16M
  • peng yu
  • Chief Financial Officer
  • 950.80K
  • baodong cheng
  • Employee Supervisors
  • 726.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data